This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université Paris Descartes. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 132 
Years Active: 2021
Title: Ana Ines Lalanne: Innovator in Diabetes Treatment
Introduction
Ana Ines Lalanne is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of diabetes. Her innovative work focuses on T-cell receptors, which play a crucial role in the immune response.
Latest Patents
Ana Ines Lalanne holds a patent for T-cell receptors (TCR) and their uses for the diagnosis and treatment of diabetes. This invention relates to T-cell receptors that recognize pancreatic beta-cell epitopes, providing a novel approach to diagnosing and treating diabetes.
Career Highlights
Throughout her career, Ana has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. Her research has been instrumental in advancing our understanding of diabetes and its treatment.
Collaborations
Ana has collaborated with notable colleagues, including Roberto Mallone and Georgia Afonso. These partnerships have enhanced her research and contributed to the development of innovative solutions in diabetes care.
Conclusion
Ana Ines Lalanne is a trailblazer in the field of diabetes research, with her patented innovations paving the way for new diagnostic and therapeutic strategies. Her work exemplifies the impact of dedicated research on improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile